Vaxtex ipo listed today on nse emerge, positive listing.
Gian Life Care Limited IPO
(i) The Company was incorporated on November 06, 2018, under the provisions of the Companies Act, 2013 by Registrar of Companies, Kanpur. On March 01, 2019, the company took over the entire running business of M/s Gian Pathology and XRays, a proprietorship concern of the promoter Mr. Arun Kumar Gupta with a view to providing diagnostic and related healthcare tests and services.[ A firm, which was formed in 1995, converted into the company in 2018 to bring IPO ]
(ii) They are primarily engaged in the business of providing diagnostic and related healthcare tests and services in Kanpur and nearby areas. They provide a broad range of diagnostic and related healthcare tests and services such as patient diagnosis services and prevention and wellness diagnosis services to its patients and healthcare providers. The customers include individual patients, hospitals, other healthcare providers and corporate customers.
(iii) They offer a broad range of approximately 1,344 tests as of March 31, 2019, it includes various tests ranging from biochemistry, clinical pathology, coagulation, cytogenetics, cytology, hematology, histopathology, immunoassay, microbiology, molecular biology and radiology services.
Objects of the Gian Life Care Limited IPO:
Gian Life Care Limited IPO Details:
|Open Date:||Dec 31 2019|
|Close Date:||Jan 03 2020|
|Face Value:||₹ 10 Per Equity Share|
|Issue Type:||fixed issue|
|Issue Size:||3.12 Cr.|
|Lot Size:||6000 Shares|
|Issue Price:||₹ 22 Per Equity Share|
|Listing At:||BSE SME|
|Listing Date:||Jan 13 2020|
Promoters And Management:
Financials of Gian Life Care Limited IPO:
Comparison With Peers:
Recommendation on Gian Life Care Limited IPO:
Lead Manager of Gian Life Care Limited IPO:
Registrar of Gian Life Care Limited IPO:
Bid Details of Gian Life Care Limited IPO as on
03 Jan 2020 | 11:56:01 PM
|Category||No.of shares offered||No. of shares bid|
Discussion on Gian Life Care Limited IPO:
Must Avoid, Lifecare field losing their impact last two decade.
There are lot of companies in diagnostics business. Every nook and corner in India is filled up with such companies. So, competition is really tough among these companies. If someone is looking to invest in the diagnostic business, then they can look at a bigger name like Dr. Lal or Thyrocare. If somebody is looking to invest in just for listing gain, then can take risk depending upon the subscription. If Qib cross >5x, they can apply for listing gain.
Today, I will review this company and give my views.
YET DOS’T COME YOUR REVIEW,VERY SLOW
Leave a Reply
You must be logged in to post a comment.